3[5]Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynmics of remifentanil [J].Anesth Analg, 1999, 89:7 - 14
4[6]Kazmaier S, Hanekop GG, Buhre W, et al. Myocardial consequences of remifentanil in patients with coronary artery disease [J]. Br J Anaesth, 2000, 84 (5):578 -583
5[7]Myre K, Raeder J, Rostrup M, et al. Catecholamine release during laparoscopic fundoplication with high and low doses of remifentanil[J]. Acta Anaesthesiol Scand,2003, 47(3):267 - 273
6[8]Casati A, Fanelli G, Albertin A, et al. Small doses of remifentanil or sufentanil for blunting cardiovascular changes induced by tracheal intubation: a doubleblind comparison [J]. Eur J Anaesthesiol, 2001, 18(2):108 - 112
7[1]Glas PSA, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil[J].Anesth Analg, 1999, 89:7 - 14
8[2]Vuyk J, Merten MJ, Olofsen E, et al. Propofol anesthesia and rational opioid selection [J]. Anesthesiology,1997, 87:1549 - 1562
9[3]Johannsen EK, Munro AJ. Remifentanil in emergency caesareansection in pre- eclampsia complicated by thrombocytopennia and abnormal liver function [J].Anesth Intensive Care, 1999, 27:527 - 529
